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Although cognitive–behavioural therapy (CBT) is an effective
treatment for depression1,2 many people with depression in
primary care remain untreated.3 An effective, acceptable and
feasible solution might be computerised CBT (CCBT).4 Com-
puterised cognitive–behavioural therapy can vary greatly in terms
of technologies used and amount of additional support. To our
knowledge, only one study so far investigated the efficacy of CCBT
for depression in primary care.5 It was shown that CCBT
(delivered on a computer in the general practice) is more effective
than usual general practitioner (GP) care. Nevertheless, the
effectiveness of CCBT via the internet in primary care remains
to be evaluated as well as the effects of CCBT combined with usual
GP care. In a randomised trial, we addressed these issues by
examining the effectiveness of online, unsupported CCBT (the
Colour Your Life programme) for depression in primary care. In
another study, this intervention was equally effective as group
CBT in people over 50 years old with subthreshold depression.6
We hypothesised that CCBT would be superior to usual GP care,
and that the combination of CCBT and usual GP care would be
more effective than CCBT alone. The Medical and Ethical
Committee of Maastricht University approved the study protocol.
The study is registered at The Netherlands Trial Register, part of
the Dutch Cochrane Centre (ISRCTN47481236).
Method
Study population and recruitment
Participants were recruited from the general population by means
of a large-scale internet-based screening in the south of The
Netherlands. A random selection of individuals was sent an
invitation letter to complete an online screening questionnaire.
Potentially eligible participants were invited to visit the research
centre to assess final eligibility. Participants were eligible if they
met the following criteria: age 18 to 65; access to the internet at
home; at least mild to moderate depressive complaints (Beck
Depression Inventory II (BDI–II)7 score 516); duration of
depressive complaints 3 months or more; no current psychological
treatment for depression; no continuous antidepressant treatment
for at least 3 months prior to entry; fluent in Dutch language; no
alcohol and/or drug dependence; and no severe psychiatric
comorbidity. To determine DSM–III–R8 Axis I diagnoses the
computerised Composite International Diagnostic Interview
(CIDI–auto)9 was used. Full details of the study method have been
described elsewhere.10
Procedure
After informed consent was obtained, participants were randomly
allocated to one of three groups: online CCBT without support
(the Colour Your Life programme); treatment as usual (TAU) by
a GP; or online, unsupported CCBT and TAU combined. Baseline
assessment took place at the research centre before randomisation
on a computer. All follow-up assessments took place at home via
the internet. Preceding an upcoming assessment point participants
received an email alert. Individuals received financial compensation
for internet use (e25).
Interventions
The CCBT programme, named Colour Your Life,11 is an online,
multimedia, interactive computer program for depression. Colour
Your Life is based on the principles of CBT and on the Dutch
version of ‘The Coping with Depression Course’ of
Lewinsohn.12,13 It consists of eight 30-min sessions and a ninth
booster session, although the duration of sessions can vary among
users. At the end of each session homework assignments are given.
Participants were advised to complete one session per week.
Participants were given log-in codes by the researchers and they
accessed CCBT at home. No assistance was offered. Colour Your
Life was originally developed for people over 50 years old6 and
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Background
Computerised cognitive–behavioural therapy (CCBT) might
offer a solution to the current undertreatment of depression.
Aims
To determine the clinical effectiveness of online,
unsupported CCBT for depression in primary care.
Method
Three hundred and three people with depression were
randomly allocated to one of three groups: Colour Your Life;
treatment as usual (TAU) by a general practitioner; or Colour
Your Life and TAU combined. Colour Your Life is an online,
multimedia, interactive CCBT programme. No assistance was
offered. We had a 6-month follow-up period.
Results
No significant differences in outcome between the three
interventions were found in the intention-to-treat and per
protocol analyses.
Conclusions
Online, unsupported CCBT did not outperform usual care,
and the combination of both did not have additional effects.
Decrease in depressive symptoms in people with moderate
to severe depression was moderate in all three interventions.
Online CCBT without support is not beneficial for all
individuals with depression.
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was adapted for an adult population (18 to 65 years) for the
current study.
Treatment as usual was delivered by the participant’s own GP
who was advised to follow guidelines from the Dutch College of
General Practitioners.14 Treatment as usual can include 4 to 5
consultations, held every second week, and antidepressant
treatment if indicated.
For each person, it was assessed whether the interventions
received were according to ‘protocol’. Adherence to CCBT was
defined as being exposed to all essential steps of the intervention,
which was operationalised as having completed five or more
sessions. Treatment as usual adherence was defined as receiving
at least four consultations or antidepressant medication.
Computerised cognitive–behavioural therapy plus TAU adherence
was defined as a combination of both.
Outcomes
The primary outcome measure was the severity of depression as
measured with the BDI–II, high scores indicating severe
depression (range 0–63).7,15,16
Secondary outcomes included the following measures. General
psychological distress was measured with the Symptom Checklist
90 (SCL–90). Scores range from 90 (no distress) to 450 (very
severe distress).17,18 The Work and Social Adjustment Scale was
used to assess impairment in social functioning attributable to
depression.19 A high score is indicative of severe impairment
(score range 0–40). The 36-item short-form Health Survey
(SF–36) was used to assess specific features of quality of
life.20–22 We used the two most relevant subscales: role limitations
caused by emotional problems and general mental health. High
scores indicate high levels of quality of life (score range 0–100).
The intensity of dysfunctional beliefs was assessed with the
Dysfunctional Attitude Scale form A.23 We used a 17-item
version,24 with a score range of 17 to 119. The higher the score,
the more dysfunctional attitudes an individual reports.
Additional measures included a healthcare use questionnaire
that we developed for the study, which measured self-reported
use of GP care, antidepressant medication and specialist care.
All outcomes were assessed at baseline and at 3-month
follow-up. In addition, the BDI–II and the Dysfunctional
Attitude Scale form A–17 were also assessed at 2 months and 6
months. The healthcare use questionnaire was assessed monthly.
Sample size
Power calculations were based on elementary head-to-head
comparisons of CCBT v. usual care and CCBT v. combination
treatment (t-test). We calculated that a sample size of 84
participants per group was needed to detect a change score of 5
(s.d. = 5.25) on the BDI–II (power 90%, a= 0.05). Adjusting for
potential withdrawal from the study (20%), we estimated that
100 participants per group were needed.
Data analysis
Preliminary tests for distribution and outliers were performed.
Skewness and kurtosis did not indicate substantial deviations from
normality for all outcomes. The analyses were based on the inten-
tion-to-treat principle (i.e. those who provided follow-up data
irrespective of treatment adherence). Only intermittent missing
data were imputed (n= 5) by calculating the mean of the values
of a previous and a subsequent time point. Missing data as a result
of loss to follow-up were not replaced by imputed values. We
tested all effects at the P50.05 level (two-tailed). All analyses were
carried out using SPSS (version 15.0.1 for Windows).
First, to test the main hypotheses, repeated-measures analyses
of variance (ANOVAs) were performed. In case of significant
time6group interactions, contrasts were conducted comparing
changes from baseline to each subsequent time point for each pair
of groups separately. Then, we computed improvement effect sizes
for BDI–II scores for each time point according to Cohen’s d
statistic,25 defined as (Mt07Mtk)/sd(Mt07Mtk). Between-group
effect sizes were determined by calculating the difference in
improvement effect sizes between two groups. Next, we
determined the proportion of participants who made clinically
meaningful changes on the BDI–II using the methodology of
Jacobson and Truax.26 This approach is based on two com-
ponents: reliable change, i.e. a decrease of 9 points; and clinically
significant change, i.e. a score below 12. Chi-squared tests were
used to test the frequency differences in reliable change, in
clinically significant change, and in reliable change plus clinically
significant change between the three groups. Based on the reliable
change plus clinically significant change proportions, the number
needed to treat was calculated.27 Finally, we conducted per
protocol analyses for treatment adherers only, using repeated-
measures ANOVAs for the BDI–II scores.
Results
Participants
Figure 1 presents the flow of the participants. Recruitment took
place from December 2005 to June 2007. Follow-up ended in
December 2007. Three hundred and three people with depression
were enrolled in the study. At 6-month follow-up, data were
available for 275 participants (attrition rate 9.2%). Reasons for
loss to follow-up were: too time-consuming (n= 8), personal
circumstances or medical illness other than a mental disorder
(n= 5) and no reason was given (n= 15). There seemed to be no
baseline differences between participants who completed all
assessments and those who were lost to follow-up (lowest
P= 0.10). Baseline characteristics of all participants are shown in
Table 1, stratified according to intervention group. Randomisation
was successful; the characteristics are fairly similar in all three
groups, although gender is not equally distributed across the groups.
Outcome of the interventions
Table 2 depicts the means and standard deviations of the clinical
outcomes at follow-up. There were no significant group6time
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Table 1 Baseline characteristics of the total sample
Variable
CCBT
(n = 100)
TAU
(n = 103)
CCBT+TAU
(n= 100)
Gender, male: n (%) 48 (48.0) 46 (44.7) 37 (37.0)
Age (18–65), years: mean (s.d.) 44.3 (11.8) 45.1 (12.2) 45.2 (10.9)
Education,a n (%)
Low 18 (18.6) 16 (16.2) 17 (17.5)
Medium 55 (56.7) 55 (55.6) 52 (53.6)
High 24 (24.7) 28 (28.3) 28 (28.9)
Partner, n (%)b 72 (73.5) 73 (72.3) 71 (73.2)
Employed, n (%)c 67 (72.0) 64 (76.2) 69 (73.4)
Major depressive episode,d n (%)
No 22 (22.0) 18 (17.5) 21 (21.0)
First 48 (48.0) 45 (43.7) 39 (39.0)
Recurrent 30 (30.0) 40 (38.8) 40 (40.0)
CCBT, computerised cognitive–behavioural therapy (Colour Your Life); TAU,
treatment as usual.
a. Data unavailable: CCBT (n = 3), TAU (n = 4), and CCBT+TAU (n = 3).
b. Data unavailable: CCBT (n= 2), TAU (n = 2), and CCBT+TAU (n= 3).
c. Data unavailable: CCBT (n = 7), TAU (n = 17), and CCBT+TAU (n = 6).
d. Assessed using the Composite International Diagnostic Interview.
Computerised cognitive–behavioural therapy for depression
75
Recruitment population
n = 217 816
Participated in screening
n = 23 139
Potentially eligible
n= 1190
Assessed for eligibility
n = 417
Randomly allocated
n= 303
Treatment as usual
(n = 103)
Reasons for no assessment:
Did not show up: n = 69
Not reachable: n = 255
Not willing: n = 176
Not eligible: n = 213
Not able to come to research centre: n = 59
Excluded:
Score BDI–II516: n = 69
Did not meet criteria: n = 35
Refused to participate: n = 4
Other reason: n = 6
Colour your life
(n = 100)
Colour your life and treatment as usual
(n = 100)
Provided follow-up data:
2 months: n = 97
3 months: n = 95
6 months: n = 92
Adhered to treatment:
Yes: n = 31
No: n = 59
Provided follow-up data:
2 months: n = 95
3 months: n = 95
6 months: n = 91
Adhered to treatment:
Yes: n = 36
No: n = 55
Provided follow-up data:
2 months: n = 96
3 months: n = 95
6 months: n = 92
Adhered to treatment:
Yes: n = 12
No: n = 81
Fig. 1 Flow of the participants. BDI–II, Beck Depression Inventory–II.
Table 2 Mean scores (s.d.) for all outcome measures in the intention-to-treat population: results from repeated-measures ANOVA
Outcome CCBT TAU CCBT+TAU Time Group Time6group
BDI–II
Baseline 28.2 (7.7) 27.9 (7.5) 27.4 (8.2) F3,271 = 71.13** F2,273 = 0.75 F6,542 = 1.22
2 months 20.6 (10.4) 22.1 (10.2) 21.7 (10.1)
3 months 20.4 (11.2) 21.4 (11.0) 19.1 (10.9)
6 months 17.8 (10.6) 18.9 (11.8) 17.5 (12.2)
DAS–A–17
Baseline 62.2 (16.8) 62.6 (17.6) 61.9 (17.4) F3,270 = 17.17** F2,272 = 0.30 F6,540 = 0.52
2 months 61.5 (16.7) 63.9 (16.3) 62.2 (18.7)
3 months 59.0 (17.5) 60.4 (17.0) 57.9 (20.0)
6 months 56.6 (15.2) 59.0 (18.3) 58.3 (19.6)
SCL–90
Baseline 182.9 (43.4) 179.9 (41.9) 180.0 (40.0) F1,282 = 1.14 F2,282 = 0.32 F2,282 = 0.33
3 months 181.5 (53.8) 178.06 (46.6) 174.7 (50.7)
SF–6 RL
Baseline 29.7 (36.4) 34.0 (35.8) 33.7 (36.8) F1,278 = 6,41* F2,278 = 1.12 F2,278 = 0.71
3 months 35.1 (37.2) 40.1 (38.9) 45.3 (41.8)
SF–36 GMH
Baseline 44.7 (13.7) 44.5 (13.9) 45.1 (14.3) F1,278 = 46.20** F2,278 = 0.19 F2,278 = 0.67
3 months 50.4 (16.5) 51.9 (15.7) 52.8 (17.5)
WSAS
Baseline 19.3 (7.2) 18.4 (6.7) 19.1 (7.7) F1,282 = 11.26** F2,282 = 1.11 F2,282 = 3.61*
3 months 18.6 (8.7) 17.7 (7.8) 15.8 (7.5)
CCBT, computerised cognitive–behavioural therapy (Colour Your Life); TAU, treatment as usual; BDI–II, Beck Depression Inventory II; DAS–A–17, 17-item Dysfunctional Attitude Scale
form A; SCL–90, Symptom Checklist 90; SF–36, 36-item short-form Health Survey; RL, role limitations due to emotional problem subscale; GMH, general mental health subscale;
WSAS, Work and Social Adjustment Scale.
*P50.05; **P50.001.
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interactions on the primary outcome measure as well as most
secondary outcomes (all P40.29). A significant interaction effect
was only found for the Work and Social Adjustment Scale
(P= 0.03). Contrasts revealed that CCBT plus TAU resulted in a
significantly greater reduction on the Work and Social Adjustment
Scale compared with CCBTalone (F1,188 = 5.63, P= 0.02) and TAU
alone (F1,188 = 4.35, P= 0.04). Since gender could have
confounded the outcomes, we corrected for this in ancillary
analyses by adding gender to the model as a between-group factor.
This did not result in a significant outcome for the BDI–II
(group6time: F6,536 = 0.94, P= 0.47) nor was there a significant
interaction between group and gender (F2,270 = 0.47, P= 0.63).
We therefore omitted this correction from all further analyses.
Effect sizes
Regarding the magnitude of the effects, all three groups had medium
to large improvement effect sizes, whereas between-group effect
sizes were trivial (Table 3). Small negative between-group effect
sizes were also found, indicating an effect in the opposite direction
to that hypothesised.
Reliable and clinical change
Table 4 shows the proportion of participants in each group who
showed a reliable change, a clinically significant change and both
for each time point. There were no significant differences between
the three groups (all P40.12). In Fig. 2 the percentage of
participants with both a reliable change and a clinically significant
change are graphically shown. We calculated the number needed
to treat (NNT) with TAU as the reference group. At 6 months
the NNT were 72 and 25 respectively for CCBT and CCBT plus
TAU.
Treatment received
In Table 5, treatment adherence and the use of healthcare services
are shown for each group during the 6 months after baseline. As
was expected, there were some significant differences between the
three groups (P50.05). More participants in TAU and CCBT plus
TAU visited their GP for depressive complaints compared with
those in the CCBT alone group. Concerning the use of CCBT,
more participants in the CCBT plus TAU group completed the last
session compared with the CCBT alone group. Furthermore, more
individuals in the TAU group received specialist mental healthcare
than in the other groups, and they received it earlier. Finally, only
a small proportion of participants in each group received an
adequate dosage of treatment (TAU: at least four consultations
or prescribed antidepressants; CCBT: at least five sessions).
Per protocol analyses
First, we compared the outcomes on the BDI–II only for those
who adhered to the treatment. Group6time interaction was not
statistically significant (F6,148 = 0.85, P= 0.53). We repeated these
analyses using a less strict definition of adherence in the CCBT
plus TAU group, i.e. adherence was defined as either an adequate
dosage of CCBTor an adequate dosage of TAU (n= 59). Again no
significant interaction effect was obtained (F6,242 = 1.67, P= 0.13).
Next, we compared the BDI–II scores between those who
adhered to the treatment protocol and those who did not within
each intervention group. None of these within-group tests
revealed statistically significant adherence6time interaction effects
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Table 3 Improvement and between-group effect sizes based on the Beck Depression Inventory II in the intention-to-treat
population
Improvement effect sizea Between-group effect sizeb
Time point 1. CCBT 2. TAU 3. CCBT+TAU 1 v. 2 3 v. 2 3 v. 1
2 months 0.71 0.63 0.57 0.08 70.06 70.14
3 months 0.71 0.69 0.74 0.02 0.05 0.03
6 months 0.86 0.81 0.89 0.05 0.08 0.03
CCBT, computerised cognitive–behavioural therapy (Colour Your Life); TAU, treatment as usual.
a. Improvement effect size = (Mt07Mtk)/sd(Mt0–Mtk).
b. Between group effect sizes = difference in improvement effect sizes between two groups.
Table 4 Proportion of participants in the intention-to-treat population showing reliable and/or clinically significant change based
on the Beck Depression Inventory II
Outcome
CCBT
n (%)
TAU
n (%)
CCBT+TAU
n (%) w2 (d.f.=2)
Reliable changea
2 months 36 (37.1) 30 (30.9) 30 (31.3) 1.06
3 months 35 (36.8) 33 (34.7) 43 (45.3) 2.48
6 months 45 (49.5) 44 (47.8) 54 (58.1) 2.25
Clinically significant changeb
2 months 24 (24.7) 16 (16.5) 16 (16.7) 2.76
3 months 22 (23.2) 18 (18.8) 28 (29.5) 3.06
6 months 26 (28.6) 29 (31.5) 33 (35.5) 1.02
Reliable change+clinically significant change
2 months 23 (23.7) 13 (13.4) 14 (14.6) 4.32
3 months 21 (22.1) 16 (16.7) 24 (25.3) 2.15
6 months 26 (28.6) 25 (27.2) 29 (31.2) 0.37
CCBT, computerised cognitive–behavioural therapy (Colour Your Life); TAU, treatment as usual.
a. Decrease of 9 points.
b. A score below 12.
Computerised cognitive–behavioural therapy for depression
(CCBT: F3,87 = 0.59, P= 0.62; TAU: F3,86 = 2.03, P= 0.12;
CCBT+TAU: F3,89 = 0.76, P= 0.52). When we used the less strict
definition of adherence in the CCBT plus TAU group, a small
effect, albeit clinically negligible, for adherence6time interaction
was obtained (F3,88 = 2.70, P= 0.05). Contrasts revealed no
differences between those who adhered to the treatment and those
who did not for each change score (P40.30).
Subgroup analyses
Since initial depressive severity was high (as can be concluded
from the baseline BDI–II scores in Table 2), we conducted
ancillary subgroup analyses. First, subgroups were formed
according to the initial median score on the BDI–II for the total
group; low scores = BDI527, and high scores = BDI527. No
statistically significant group6time interaction effects were found
in each subgroup (BDI527: F6,262 = 1.27, P= 0.27; BDI527:
F6,270 = 1.15, P= 0.34). Second, subgroups were formed based on
the presence or absence of a major depressive episode. In the no
major depressive episode subgroup, the group6time interaction
was not statistically significant (F6,84 = 1.02, P= 0.42), whereas a
significant interaction was obtained in the major depressive
episode group (F6,448 = 2.25, P= 0.04). Contrasts revealed a
significant effect only for change from baseline to 3-month
follow-up in favour of the CCBT plus TAU group compared with
the TAU alone group (F1,161 = 6.03, P= 0.02).
Discussion
Main results
In contrast to our hypotheses, the findings suggest that there are
no meaningful differences between CCBT, TAU, and CCBT plus
TAU combined during 6 months of follow-up in terms of
depressive severity, quality of life, dysfunctional beliefs and general
psychological distress. Although we found medium improvement
effect sizes in depressive severity for all interventions, the between-
group effect sizes were rather small or even negative. Moreover,
per protocol analysis between and within groups revealed no
differences between the interventions either. Finally, we found that
treatment adherence was low in all interventions. It should be
noted that at 3 months, a significant effect was found for social
functioning in favour of the combined treatment. We are reluctant
to interpret this effect given the high number of statistical tests we
performed.
Previous studies
To be able to compare the effects of CCBT in our study with
previous ones, we calculated the usual Cohen’s d (i.e. dividing
the pre–post difference by the pooled standard deviation) for
the 2-month follow-up period. Our improvement effect size for
Colour Your Life (d= 0.84) was smaller than in the previous study
on Colour Your Life (d= 1.00)6 and than in the previous primary
care study5 (d= 1.27). The between-group effect size for Colour
Your Life relative to TAU was smaller (d= 0.20) than found for
Colour Your Life in a previous study6 (d= 0.55), CCBT in primary
care5 (d= 0.65), online CCBT with support (d= 1.05),28 and
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Fig. 2 Percentage of participants in the intention-to-treat
population with reliable and clinically significant change.
Table 5 Treatment adherence and use of mental healthcare services during 6 months of follow-up in the intention-to-treat
population
Variable CCBT TAU CCBT+TAU
Use of GP carea
Depression related GP contact, n (%) 25 (28.7) 66 (73.3) 67 (73.3)***
Details of those who visited the GP, mean (s.d.)
Number of contacts 4.7 (4.5) 3.7 (3.4) 2.9 (3.3)
Prescription of antidepressants 8 (32.0) 25 (37.9) 17 (25.4)
Use of other mental healthcarea
Use of antidepressants, n (%) 12 (13.8) 24 (26.7) 23 (25.0)
Specialist mental healthcare, n (%) 17 (23.6) 33 (36.7) 22 (23.9)*
Details of those who received specialist mental healthcare, mean (s.d.)
Month of first contact 3.4 (1.7) 2.0 (1.1) 2.5 (1.5)*
Number of contacts 7.8 (6.2) 7.5 (6.3) 7.3 (5.2)
Use of the CCBT programme
Completed first session, n (%) 72 (72.0) – 76 (76.0)
Completed last session, n (%) 14 (14.0) – 26 (26.0)*
Number of sessions, mean (s.d.) 3.4 (3.0) – 4.0 (3.4)
Protocol adherence, n (%)
Adequate dosage of TAU – 31 (34.4) 26 (28.3)
Adequate dosage of CCBT 36 (36.0) – 47 (47.0)
Overall treatment adherence 36 (36.0) 31 (34.4) 12 (12.9)***
CCBT, computerised cognitive–behavioural therapy (Colour Your Life); TAU, treatment as usual; GP, general practitioner. Adequate dosage of TAU= at least four consultations
or antidepressant prescription; adequate dosage of CCBT= at least five sessions. Chi-squared tests for categorical variables and t-tests/ANOVAs for continuous variables were used.
a. Data unavailable: CCBT (n=13), TAU (n=13), and CCBT+TAU (n=8).
*P50.05; ***P50.001.
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CCBT with shortened face-to-face therapy (d= 1.14).29
Comparable effect sizes were found for bibliotherapy with
minimal contact in primary care (d= 0.18),30 and online CCBT
without support (d= 0.22).31 It should be noted here that most
of these studies used other comparison groups, making it difficult
to directly compare the effects.
There are several reasons that may explain the small effects in
our study. First of all, one might argue that Colour Your Life itself
was less effective than other CCBT programmes. Results from the
previous study using Colour Your Life seemed very promising for
subthreshold depression in people over 50 years old.6,32 However,
in that study, baseline assessment of the primary outcome was
conducted after randomisation, which could have violated the
results.
Second, the way CCBTwas offered might explain the different
outcomes. Various technologies can be used, ranging from the
telephone to CD–ROMs, hi-tech computers, palmtops and the
internet.33–36 The latest interventions use highly sophisticated
computer systems, which might stimulate and improve
engagement and motivation.37 Although Colour Your Life makes
full use of the current technologies, this might not have been
enough to stimulate treatment adherence. We think that the lack
of clinician support might account for the poor adherence and
response to online, unsupported CCBT that we observed. Similar
studies also showed a lack of response,31,38,39 whereas studies that
offered some form of support reported more treatment adherence
and larger effects with online CCBT for several psychological
disorders.28,33,40–42 Poor treatment adherence in our study might
thus have masked potential effects of the interventions, but our
ancillary per protocol analyses did not reveal differences between
the treatment groups either. We did observe a small trend in
favour of the group receiving CCBT plus TAU as opposed to both
single therapies for reliable change and clinically significant
change, and in favour of the subgroup with a major depressive
episode. However, our combined group cannot be seen as
supported self-help, since the GP was not directly involved in
the CCBT intervention.
Third, the low effect sizes in all three interventions might be
attributable to our study sample, which was more severely
depressed than in previous studies.5,28 The mean starting levels
on the BDI–II were even higher than generally seen in primary
care patients with depression.43 Chronicity might also have
negatively influenced the outcome.44 Unfortunately, we do not
have details of the exact duration of each current depressive
episode. Moreover, because of our recruitment strategy our sample
did not consist of active help-seekers, despite the high severity
of their depression. This might have resulted in less-motivated
participants.
Finally, we should note that none of our interventions did
particularly well. Clinical improvement was approximately
30% in all groups. Given the fact that the response rate with
pill-placebo is generally high in depression (i.e. 30–40%),45,46 we
might have observed the natural course of depression in the
current study. Nevertheless, improvement in our study was
somewhat greater than seen in patients with depression on waiting
lists.47
Implications
Our findings might have several implications for the primary care
treatment of depression. First, treatment might only be indicated
for those who ‘get stuck’ in their depression, since depressive
symptoms seem to improve over time without adhering to
treatment, as was shown in the current study. Second, for more
severe depression online CCBT offered with some support might
be more helpful. Third, this group of people with more severe
depression might also fare better in secondary mental healthcare,
where they can receive psychotherapy or antidepressant medi-
cation, for which larger effect sizes have been found relative to
our effect size.48,49 Fourth, careful implementation of unsupported
online self-help is warranted. Stepped-care and collaborative care
models might be viable options.50,51 Fifth, if large differences in
costs between the interventions exist, this might be a reason to
choose one primary care treatment over another. Only one study
so far has conducted an economic evaluation of CCBT.52 It was
shown that supported CCBT was both more effective and more
costly compared with usual GP care. When willing to pay for an
additional unit of effect, CCBT could be very cost-effective.52 In
a further paper, we will report the economic evaluation of Colour
Your Life without support in primary care. Finally, qualitative
process evaluation and information on individuals’ experiences
(e.g. treatment satisfaction) might also help to decide which treat-
ment should be given to an individual. The acceptability of CCBT
both before and after treatment (e.g. expectancy, credibility and
satisfaction) has rarely been assessed in research.53 Taken together,
more work needs to be done to optimise treatment adherence in
CCBT, to determine the best way of providing online and
unsupported CCBT in actual practice and to determine for whom
CCBT is best suited.
Methodological considerations
We feel that our results cannot be explained by clear method-
ological flaws. Our large sample size (n= 303) provided us with
sufficient power to detect significant differences between the
interventions. Furthermore, we had a relatively low attrition rate,
so we feel confident that no biases occurred as a result of missing
data. Finally, we were able to recruit participants from the general
population. Unlike in samples selected in general practices or
clinics, no biases occurred as a result of help-seeking behaviour
of individuals and illness recognition by physicians, which is often
a problem in depression.54
Some limitations of the present study should also be noted. All
our outcomes were measured online and one might question the
equality of computerised questionnaires and paper and pen
versions. However, there are sufficient indications that com-
puterised and paper and pen questionnaires show similar
construct validity.55–57 Furthermore, we relied on self-report
measures at follow-up and, as a result, we have no information
on actual diagnoses of depressive episodes at follow-up. Finally,
it should be noted that the number of participants included is
merely a fraction of the original recruitment population (i.e.
0.14%), despite the high prevalence of depression in the
community.58,59 Participants had to come to the research centre
for an intake, which could have reduced the number of applicants,
but could also have increased the adherence. Overall, the low
response rate in the current study might be discouraging to the
belief of many researchers that online CCBT can be disseminated
to large parts of the general population.60
In the current study we were unable to confirm the previously
reported high effectiveness of CCBT using online, unsupported
Colour Your Life. Moreover, adding Colour Your Life to treatment
as usual had no extra beneficial effects. These findings cannot
merely be explained by the lack of treatment adherence, since
per protocol analyses showed no differences between the inter-
ventions either. It is entirely possible that we have observed
natural, although not complete, recovery in a group of people
with moderate and severe depression who showed a decrease in
symptoms irrespective of the nature of the intervention they
received. Computerised cognitive–behavioural therapy, offered
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online without any support, is not beneficial for all people with
depression (nor is any treatment of any kind). Adding therapist
support to CCBT or treatment in secondary mental healthcare
might have yielded better results in this group of people with
depression.
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Stigma
Peter Byrne
Stigma is a prejudice (negative attitude) based on stereotypes usually leading to discrimination. Familiar mental illness stereotypes (weak,
violent, comic) drive prejudice in society. Discrimination ranges from simple avoidance through exit life events (relationship, employment
and housing losses) and institutional discrimination (denial of health interventions, insurance, jury service, visa inter alia). Stigma-
discrimination cannot occur without a power differential. When a person with mental health problems shares societal prejudices, their
self-stigma contributes to further morbidity and status loss. Reducing stigma requires multiple interventions: a language of inclusion (no more
‘schizophrenics’), legal and organisational reforms, and cultural changes based on empowerment.
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